文献速递神经肿瘤

COX7A2高表达与胶质瘤患者良好预后相关

Overexpression of COX7A2 is associated with a good prognosis in patients with glioma.
PubMed 文献 · J Neurooncol · 2017-10-27

研究纳入126例胶质瘤手术组织样本,随访4至51个月,用免疫组化检测COX7A2表达。126例中86例(68.3%)高表达COX7A2,高表达者总生存期更长、预后更好,多因素分析显示COX7A2高表达是独立的生存预后指标。

要点

  • 126例胶质瘤样本中86例(68.3%)COX7A2高表达。
  • COX7A2高表达者总生存期更长、预后更好。
  • 多因素分析显示COX7A2高表达是独立的生存预后指标。

核心结论

  • COX7A2高表达与胶质瘤患者良好预后相关,多因素分析显示其为独立的生存预后指标,作者认为COX7A2可作为有价值的胶质瘤预后标志物。

研究设计与样本

  • 研究纳入126例胶质瘤手术组织样本,患者随访4至51个月,采用免疫组化检测COX7A2表达,并进行生存分析与多因素分析。

主要发现

  • 126例石蜡包埋胶质瘤活检样本中86例(68.3%)显示COX7A2高表达。
  • 按WHO分类分组的患者间COX7A2表达水平存在显著差异。
  • Kaplan-Meier生存分析显示COX7A2高表达患者总生存时间更长、预后更好。
  • 基于Tumor Glioma French 284数据库、Tumor Glioblastoma TCGA 540数据库和Tumor Glioma Kawaguchi 50数据库的微阵列分析证实COX7A2高表达与胶质瘤患者良好预后相关。
  • 多因素分析显示COX7A2高表达是独立的生存预后指标。

临床怎么用

  • 作者认为COX7A2可作为有价值的胶质瘤预后标志物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cytochrome c oxidase subunit 7A2 (COX7A2) is a nuclear-encoded polypeptide involved in assembly and regulation of cytochrome c oxidase (COX). Changes in the respiratory chain as big complex are known to be associated with cancer, but little research has been performed to discover COX7A2 as a prognostic marker in glioma. In the present study, we investigated COX7A2 expression and its prognostic significance in glioma. Glioma surgical tissue samples were taken from 126 patients who had been followed up from 4 to 51 months. Immunohistochemistry were used to test COX7A2 expression in the 126 tumor samples. Eighty-six of 126 (68.3%) paraffin-embedded glioma biopsies showed high expression of COX7A2. Statistical analysis displayed that there was significant difference of COX7A2 expression level in patients categorized according to WHO classification. Kaplan-Meier survival analysis revealed that patients with higher COX7A2 expression had longer overall survival time and better prognosis. R2: microarray analysis based on Tumor Glioma French 284 database, Tumor Glioblastoma TCGA 540 database, and Tumor Glioma Kawaguchi 50 database testified that high expression of COX7A2 is associated with a good prognosis in patients with glioma. Multivariate analysis showed that COX7A2 high expression was an independent prognostic indicator for survival. Our results suggest that COX7A2 could be served as a valuable prognostic marker of glioma.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Deng S, Li Y, Yi G, et al. Overexpression of COX7A2 is associated with a good prognosis in patients with glioma. J Neurooncol. 2017. PMID: 29079956. doi:10.1007/s11060-017-2637-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。